BIO vs TTI · rev $2.58B vs P/E 170, $1.50B cap
BIO (BIO) versus Tetra Technologies Inc (TTI) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Tetra Technologies Inc (TTI) is a conglomerates company listed on NYSE.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
TTI does not have a complete income-statement cache yet.
BIO currently screens at market cap $0. TTI currently screens at market cap $1.50B and trailing P/E 169.5.
Not investment advice. Open the BIO and TTI stock pages for the full models.
Not investment advice.